Stay updated on Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a routine version/UI update and does not modify study details or eligibility on the page.
    Difference
    0.1%
    Check dated 2026-03-12T00:29:25.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Site update deployed Revision v3.4.2 and removed the funding-lapse notice and Revision v3.4.1; these are administrative changes and do not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T12:00:33.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding and a new site revision tag (v3.4.1) were added, while the previous revision tag (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:27:44.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated metadata labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with revision v3.4.0; previous labels used 'met' lowercase and 'No FEAR Act data', and revision was v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T06:23:14.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A new site revision label (Revision: v3.3.4) replaces the previous Revision: v3.3.3; this is a backend CMS update and does not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:04:50.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a Locations section specifying Michigan as the study site. Removed the HHS Vulnerability Disclosure link and updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:29:00.000Z thumbnail image

Stay in the know with updates to Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.